BPC 157 and TB 500: Injury Healing Peptides Jonathan L. Glashow posted on the topic LinkedIn Gray Market Peptides: So Much Hype, So Little Data The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Peptides Lack Reliable Safety Information, Watchdog Warns I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA